# PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

Source: https://onco.cc/trials/nct07043907/  
OnCo record `nct07043907` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in lung cancer, run by Shenzhen Celconta Life Science Co., Ltd., not yet recruiting.

## Summary

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC is a phase 2, interventional study registered as NCT07043907 by Shenzhen Celconta Life Science Co., Ltd., with a registry enrolment figure of 115 participants, started 2025-07-08 and due to reach its primary completion in 2028-07-08. Interventions recorded: PANK-003 cell injection combined with standard postoperative adjuvant chemotherapy. Conditions listed: Stage IIIA Non-small Cell Lung Cancer. Primary outcome: Incidence and severity of adverse events (AEs); Disease Free Surviva Percentage（DFS%）. Lung eligibility wording from the registry: "Patients with histologically confirmed stage IIIA NSCLC (T4N0M0, T3-4N1M0, T1a-2bN2M0) who underwent R0 resection and received postoperative adjuvant chemotherapy (Exclusion of EGFR sensitizing mutations and ALK fusion); and who received the first dose of PANK-003 cell injection combined with postop". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07043907
- Phase: 2
- Setting: A Single-center, Single-arm Exploratory Clinical Trial on the Safety and Efficacy of PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA Non-Small Cell Lung Cancer
- Sponsor: Shenzhen Celconta Life Science Co., Ltd.
- Enrolled: 115

## Sources

- ClinicalTrials.gov NCT07043907: https://clinicaltrials.gov/study/NCT07043907

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07043907.json